CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Medical Edge from Mayo Clinic

Medical Edge from Mayo Clinic is a Rochester, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Arsenal Medical

Arsenal Medical is a Watertown, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Diagnostic Centers of America

Diagnostic Centers of America is a Delray Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IntelliType Corporation

IntelliType Corporation is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Integrated Medical Management

Integrated Medical Management is a Las Vegas, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.